GLSI
GRNWICH LIFESCI (GLSI)
NASDAQ
$22.98-$0.05 (-0.22%)
Price as of Jun 23, 2026 7:42 PM EDT
  • $348.6M
    Market Cap
  • 154.48%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
434,732
0.00%
Gross Profit
0
N/A
0
N/A
0
+100.00%
-434,732
0.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-17.2M
+32.96%
-13.0M
+68.24%
-7.7M
+18.89%
-6.5M
+81.93%
Depreciation and Amortization Expense
1,779
-50.75%
3,612
0.00%
3,612
0.00%
3,612
0.00%
Total Operating Expenses
19.4M
+21.46%
16.0M
+71.66%
9.3M
+16.01%
8.0M
+74.87%
Operating Profit
-19.4M
+21.46%
-16.0M
+71.66%
-9.3M
+16.01%
-8.0M
+74.87%
Interest Income
89,700
-59.78%
223,008
-48.86%
436,063
+102.80%
215,017
+685.68%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
89,700
-59.78%
223,008
-48.86%
436,063
+102.80%
215,017
+685.68%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-19.4M
+21.46%
-16.0M
+71.66%
-9.3M
+16.01%
-8.0M
+74.87%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-15.8M
+77.57%
-8.9M
+13.63%
-7.8M
+71.21%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-15.8M
+77.57%
-8.9M
+13.63%
-7.8M
+71.21%
Basic EPS and Net Income
-1.43
+18.18%
-1.21
+75.36%
-0.69
+13.11%
-0.61
+74.29%
Diluted EPS and Net Income
-1.43
+18.18%
-1.21
+75.36%
-0.69
+13.11%
-0.61
+74.29%
Basic Weighted Average Shares
13.5M
+4.00%
13.0M
+1.30%
12.8M
-0.51%
12.9M
-0.23%
Diluted Weighted Average Shares
13.5M
+4.00%
13.0M
+1.30%
12.8M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
6.2M
+50.98%
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.2M
+50.98%
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
Total Current Assets
6.2M
+50.98%
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
6.2M
+50.91%
4.1M
-41.47%
7.0M
-48.10%
13.5M
-50.48%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
275,154
0.00%
Total Current Liabilities
5.8M
+273.45%
1.6M
+429.79%
294,406
+11.98%
262,905
-31.74%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
81,553
+21.30%
67,230
-58.41%
161,644
-53.26%
Total Liabilities
5.8M
+273.45%
1.6M
+429.79%
294,406
+11.98%
262,905
-31.74%
Retained Earnings
-87.1M
+31.72%
-66.2M
+31.35%
-50.4M
+21.44%
-41.5M
+23.26%
Total Stockholders Equity
353,217
-86.06%
2.5M
-62.18%
6.7M
-49.29%
13.2M
-50.75%
Total Shares Outstanding
14.3M
+8.71%
13.2M
+2.37%
12.8M
0.00%
12.8M
-2.28%
Cash Flow
Cash from Operating Activities
-9.9M
+36.43%
-7.3M
+12.16%
-6.5M
+4.49%
-6.2M
+44.47%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
12.0M
+174.64%
4.4M
N/A
N/A
N/A
-7.5M
-365.79%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
-284.78%
+227.82%
-86.87%
+125.87%
-38.46%
+135.16%
Return on Equity
N/A
N/A
-341.95%
+282.93%
-89.30%
+128.50%
-39.08%
+132.85%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.06
-59.57%
2.62
-88.95%
23.74
-53.66%
51.23
-27.47%
Cash Ratio
1.06
-59.57%
2.62
-88.95%
23.74
-53.66%
51.23
-27.47%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow